3-bromo-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2,6-dimethoxybenzamide is a dimethoxybenzene. Remoxipride is an atypical antipsychotic agent that is specific for dopamine D2 receptors. It gained approval in the UK in 1989 but was withdrawn in 1993 after it was found to be associated with an increased incidence of aplastic anemia. An antipsychotic agent that is specific for dopamine D2 receptors. It has been shown to be effective in the treatment of schizophrenia. Its therapeutic use is listed as antipsychotics. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Remoxiprida and Remoxipridum. Its PubChem CID is 54477.
Remoxipride
| CAS No | 80125-14-0 |
|---|---|
| Molecular Formula | C16H23BrN2O3 |
| Molecular Weight | 371.27 g/mol |
| Synonyms | 3-bromo-N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2,6-dimethoxybenzamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
3-bromo-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2,6-dimethoxybenzamide is a dimethoxybenzene. Remoxipride is an atypical antipsychotic agent that is specific for dopamine D2 receptors.
The listed CAS number is 80125-14-0.
The listed molecular formula is C16H23BrN2O3.
The listed molecular weight is 371.27 g/mol.
3-bromo-N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2,6-dimethoxybenzamide.
The source lists Remoxiprida and Remoxipridum.